Expression levels of adenosine receptors in hippocampus and frontal cortex in argyrophilic grain disease

被引:15
|
作者
Perez-Buira, S.
Barrachina, M.
Rodriguez, A.
Albasanz, J. L.
Martin, M.
Ferrer, I.
机构
[1] Univ Barcelona, Fac Med, Hosp Llobregat,Serv Anat Patol, Hosp Univ Bellvitge,IDIBELL,Inst Neuropatol, Barcelona 08907, Spain
[2] Univ Castilla La Mancha, Ctr Reg Invest Biomed, Fac Quim, Dept Quim Inorgan Organ & Bioquim, E-13071 Ciudad Real, Spain
关键词
argyrophilic grain disease; adenosine receptors; adenylyl cyclase;
D O I
10.1016/j.neulet.2007.06.049
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Expression of adenosine receptors of the A 1, A2A and A2B type has been examined in the post-mortem frontal cortex and hippocampus in argyrophilic grain disease (AGD), a tauopathy affecting the hippocampus but usually not the frontal cortex, in an attempt to learn about the modulation of the adenosine pathway in this disorder. Significant increased levels of A1, but not of A2A and A2B, have been observed in AGD in the hippocampus but not in the frontal cortex, when compared with age-matched controls. This is accompanied by increased levels of adenylyl cyclase (AC), an effector of A1, and by increased (although not significant) percentage of inhibition of forskolin-stimulated AC by the A I agonist cyclohexyladenosine in the hippocampus in AGD. These findings indicate sensitization of A1/AC in the hippocampus in AGD, and support a putative activation of the A1/AC pathway that may facilitate protection of this preferentially involved region in AGD. (C) 2007 Published by Elsevier Ireland Ltd.
引用
收藏
页码:194 / 199
页数:6
相关论文
共 50 条
  • [1] Expression levels of adenosine receptors in hippocampus and frontal cortex in argyrophilic grain disease
    Perez-Buira, Sandra
    Barrachina, Marta
    Rodriguez, Agustin
    Albasanz, Jose Luis
    Martin, Mairena
    Ferrer, Isidro
    [J]. PURINERGIC SIGNALLING, 2008, 4 : S40 - S41
  • [2] SEROTONIN RECEPTORS IN HIPPOCAMPUS AND FRONTAL-CORTEX
    SEEMAN, P
    WESTMAN, K
    COSCINA, D
    WARSH, JJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 66 (2-3) : 179 - 191
  • [3] Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease
    Albasanz, Jose L.
    Perez, Sandra
    Barrachina, Marta
    Ferrer, Isidro
    Martin, Mairena
    [J]. BRAIN PATHOLOGY, 2008, 18 (02) : 211 - 219
  • [4] NMDA receptors in frontal cortex and hippocampus of alcohol consumers
    Villegas, Eulalia
    Estruch, Ramon
    Mengod, Guadalupe
    Cortes, Roser
    [J]. ADDICTION BIOLOGY, 2011, 16 (01) : 163 - 165
  • [5] Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia
    Moody, Cassidy L.
    Funk, Adam J.
    Devine, Emily
    Homan, Ryan C. Devore
    Boison, Detlev
    Mccullumsmith, Robert E.
    O'Donovan, Sinead M.
    [J]. SCHIZOPHRENIA BULLETIN, 2020, 46 (03) : 690 - 698
  • [6] Adenosine receptors are increased and sensitized in the frontal cortex from Alzheimer's disease cases
    Albasanz, Jose Luis
    Perez, Sandra
    Barrachina, Marta
    Ferrer, Isidro
    Martin, Mairena
    [J]. PURINERGIC SIGNALLING, 2008, 4 : S32 - S32
  • [7] Expression of muscarinic and dopaminergic receptors and monoamine levels frontal cortex of epileptic rats
    Freitas, RM
    Oliveira, AD
    Vasconcelos, SMM
    Sousa, FCF
    Viana, GSB
    Fonteles, MMF
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 83 (02) : 302 - 306
  • [8] Adenosine A2A receptors are up-regulated in Pick's disease frontal cortex
    Albasanz, Jose Luis
    Rodriguez, Agustin
    Ferrer, Isidro
    Martin, Mairena
    [J]. BRAIN PATHOLOGY, 2006, 16 (04) : 249 - 255
  • [9] The effects of benzophenone-3 on apoptosis and the expression of sex hormone receptors in the frontal cortex and hippocampus of rats
    Krzyzanowska, Weronika
    Pomierny, Bartosz
    Starek-Swiechowicz, Beata
    Broniowska, Zaneta
    Strach, Beata
    Budziszewska, Boguslawa
    [J]. TOXICOLOGY LETTERS, 2018, 296 : 63 - 72
  • [10] Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease
    Lidström, AM
    Bogdanovic, N
    Hesse, C
    Volkman, I
    Davidsson, P
    Blennow, K
    [J]. EXPERIMENTAL NEUROLOGY, 1998, 154 (02) : 511 - 521